Safety and immunogenicity of full-dose quadrivalent influenza vaccine in children 6-35 months of age in China: A randomized, double-blind, clinical trial

• Main Authors: Shilei Wang (Author), Yanxia Wang (Author), Dandan Chen (Author), Wenting Xu (Author), Peng Duan (Author), Wei Ji (Author), Weijun Liu (Author), Weijin Huang (Author), Bing Wu (Author), Wenqing Chai (Author), Chenyan Zhao (Author), Yongli Yang (Author), Jian Luo (Author), Dongyang Zhao (Author), Xiuling Li (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

A half-dose influenza vaccine (7.5 μg hemagglutinin per strain) has been used for children under 3 years of age for a long time. However, several studies indicate that a full-dose influenza vaccine (15 μg hemagglutinin per strain) may bring more benefit to this population without increasing the risk...